Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

9.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.0K
Conserved Binding Sites01:49

Conserved Binding Sites

5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Conserved Binding Sites01:49

Conserved Binding Sites

2.0K
2.0K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

6.7K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.7K
Ligand Binding Sites02:40

Ligand Binding Sites

15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset.

Scientific reports·2026
Same author

11<sup>th</sup> National Conference of the French Chemoinformatics Society (SFCi).

Molecular informatics·2026
Same author

Assessing the problem of excitation light scattering in high-viscosity jets used in serial crystallography sample delivery.

Journal of applied crystallography·2026
Same author

Mapping ligands for MT<sub>1</sub>/MT<sub>2</sub> and 5-HT<sub>2C</sub> receptors: Chemotypes, SAR, and polypharmacology.

Drug discovery today·2026
Same author

From erbium(iii) to samarium(iii): generalized photomodulation of NIR to red lanthanide luminescence with a DTE ligand and its versatile role in the quenching processes.

Chemical science·2025

Related Experiment Video

Updated: Feb 21, 2026

An Assay for Quantifying Protein-RNA Binding in Bacteria
07:02

An Assay for Quantifying Protein-RNA Binding in Bacteria

Published on: June 12, 2019

7.0K

Toward Understanding Mcl-1 Promiscuous and Specific Binding Mode.

Jade Fogha1, Bogdan Marekha1, Marcella De Giorgi1

  • 1Normandie Univ, UNICAEN, CERMN, FR CNRS 3038 INC3M , SF 4206 ICORE bd Becquerel, F-14000 Caen, France.

Journal of Chemical Information and Modeling
|October 11, 2017
PubMed
Summary

Myeloid cell leukemia 1 (Mcl-1) protein promotes cancer cell survival. This study reveals a specific binding pattern involving a negatively charged patch on BH3-only peptides, crucial for Mcl-1 interaction and potential cancer therapy development.

More Related Videos

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.6K
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
17:12

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS

Published on: December 20, 2010

16.1K

Related Experiment Videos

Last Updated: Feb 21, 2026

An Assay for Quantifying Protein-RNA Binding in Bacteria
07:02

An Assay for Quantifying Protein-RNA Binding in Bacteria

Published on: June 12, 2019

7.0K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.6K
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
17:12

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS

Published on: December 20, 2010

16.1K

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Myeloid cell leukemia 1 (Mcl-1) is an anti-apoptotic protein overexpressed in cancers, contributing to tumor cell survival.
  • Inhibiting Mcl-1 is crucial for initiating apoptosis, requiring interaction with BH3-only proteins.
  • Understanding the specificity of BH3-only protein binding to Mcl-1 is essential for targeted cancer therapies.

Purpose of the Study:

  • To elucidate the molecular basis of BH3-only peptide interactions with Mcl-1.
  • To identify specific binding patterns that dictate BH3-only selectivity for Mcl-1.
  • To explore potential Mcl-1 specific binding motifs for therapeutic targeting.

Main Methods:

  • Utilized molecular dynamics simulations to analyze Mcl-1/BH3-only peptide interactions.
  • Investigated the role of conserved residues and structural motifs in protein-protein binding.
  • Analyzed the contribution of hydrophobic residues and charged patches in peptide binding specificity.

Main Results:

  • Confirmed the importance of four conserved hydrophobic residues and a conserved aspartic acid in BH3-only peptides for Mcl-1 binding.
  • Identified a fifth hydrophobic residue in the C-terminal and an N-terminal negatively charged patch as critical for Mcl-1 fixation.
  • These findings suggest a novel Mcl-1 specific binding pattern.

Conclusions:

  • The study elucidates key molecular interactions governing BH3-only peptide binding to Mcl-1.
  • A negatively charged patch in BH3-only peptides is proposed as a novel Mcl-1 specific binding motif.
  • This discovery holds potential for developing targeted therapies against Mcl-1-dependent cancers.